Skip to main content
TipRanks
Go Ultimate75% OFF

Enrico Cipro Vanni Insider Profile

4 Followers

Enrico Cipro Vanni, former Director at Advanced Oncotherapy, holds 4.08M shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Enrico Cipro Vanni Bought 80,000 shares of Advanced Oncotherapy on Dec 29, 2022 for an estimated value of 10.00K .

Enrico Cipro Vanni's Trading History

AVO
Advanced Oncotherapy
Dec 29, 2022―Informative Buy10.00K£71.34K
GB:AVO
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 29, 2022Informative Buy£10.00K80,000£12.00-86.70%―
Aug 03, 2022Informative Buy£50.00K200,000£25.00-91.50%―
Aug 03, 2022Uninformative Buy£75.00K300,000£25.00――
Mar 02, 2022Informative Buy£26.50K100,000£26.00-82.60%―
Aug 11, 2021Informative Buy£200.00K500,000£40.00-44.80%―

You May Also Like

Enrico Cipro Vanni insider profile FAQ

What is the percentage of profitable transactions made by Enrico Cipro Vanni?
The percentage of profitable transactions made by Enrico Cipro Vanni is 36%.
What is the average return per transaction made by Enrico Cipro Vanni?
The average return per transaction made by Enrico Cipro Vanni is -2.40%.
What stocks does Enrico Cipro Vanni hold?
Enrico Cipro Vanni holds: GB:AVO stocks.
What was Enrico Cipro Vanni’s latest transaction?
Enrico Cipro Vanni’s latest transaction was an Informative Buy of 10.00K .
What was Enrico Cipro Vanni's most profitable transaction?
Enrico Cipro Vanni’s most profitable transaction was an Informative Buy of GB:AVO stock on August 1, 2017. The return on the trade was 209.00%.
What is Enrico Cipro Vanni's role in Advanced Oncotherapy?
Enrico Cipro Vanni's role in Advanced Oncotherapy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.